These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16457056)

  • 1. [Coverage and association with clinical variables of antipneumococcal vaccination of the population over 65 years old in Tarragona-Valls].
    Vila Córcoles A; Ochoa Gondar O; Ansa Echeverría X; Bladé Creixenti J; Palacios Llamazares L; Fuentes Bellido CM
    Rev Esp Salud Publica; 2005; 79(6):645-54. PubMed ID: 16457056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up.
    Vila-Córcoles A; Ochoa-Gondar O; Ester F; Sarrá N; Ansa X; Saún N;
    BMC Public Health; 2006 Sep; 6():231. PubMed ID: 16981982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
    Vila-Córcoles A; Ochoa-Gondar O; Hospital I; Ansa X; Vilanova A; Rodríguez T; Llor C;
    Clin Infect Dis; 2006 Oct; 43(7):860-8. PubMed ID: 16941367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
    Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
    Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink study.
    Jackson LA; Baxter R; Naleway AL; Belongia EA; Baggs J
    BMC Infect Dis; 2009 Mar; 9():37. PubMed ID: 19321001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evolution of the antipneumococcal vaccination coverage among children in the region of Tarragona, Spain, 2002-2011].
    Vila Córcoles A; Ochoa Gondar O; Gutiérrez Pérez A; de Diego Cabanes C; Vila Rovira A; González Lamban B
    Rev Esp Salud Publica; 2012 Dec; 86(6):637-43. PubMed ID: 23325138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with pneumococcal vaccination among an urban elderly population in China.
    Liu S; Xu E; Liu Y; Xu Y; Wang J; Du J; Zhang X; Che X; Gu W
    Hum Vaccin Immunother; 2014; 10(10):2994-9. PubMed ID: 25483646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects.
    Vila-Córcoles A; Ochoa-Gondar O; Llor C; Hospital I; Rodríguez T; Gómez A
    Eur Respir J; 2005 Dec; 26(6):1086-91. PubMed ID: 16319340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pneumococcal polysaccharide vaccine on incidence and mortality after pneumonia in adults aged ≥60 years-a population-based retrospective cohort study.
    Kolditz M; Schmitt J; Pletz MW; Tesch F
    Clin Microbiol Infect; 2018 May; 24(5):500-504. PubMed ID: 28830805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain.
    Jiménez-García R; Ariñez-Fernandez MC; Hernández-Barrera V; Garcia-Carballo MM; de Miguel AG; Carrasco-Garrido P
    J Infect; 2007 Jan; 54(1):65-74. PubMed ID: 17049991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases: a matched case-control study.
    Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Gutierrez-Perez A; Vila-Rovira A;
    Hum Vaccin Immunother; 2012 May; 8(5):639-44. PubMed ID: 22634442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pneumococcal vaccination coverage in at-risk children in Catalonia].
    González R; Armadans L; Martínez X; Moraga F; Campins M
    Enferm Infecc Microbiol Clin; 2015 Nov; 33(9):597-602. PubMed ID: 25703208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza and pneumococcal vaccine distribution and use in primary care and hospital settings in Scotland: coverage, practice and policies.
    Kyaw MH; Wayne B; Chalmers J; Jones IG; Campbell H
    Epidemiol Infect; 2002 Jun; 128(3):445-55. PubMed ID: 12113489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Missed opportunities in antipneumococcal vaccination. Can something more be done for prevention?
    Arencibia Jiménez M; Navarro Gracia JF; Delgado de Los Reyes JA; Pérez Torregrosa G; López Parra D; López García P
    Arch Bronconeumol; 2014 Mar; 50(3):93-8. PubMed ID: 24315186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predictive of increased influenza and pneumococcal vaccination coverage in long-term care facilities: the CMS-CDC standing orders program Project.
    Bardenheier BH; Shefer A; McKibben L; Roberts H; Rhew D; Bratzler D
    J Am Med Dir Assoc; 2005; 6(5):291-9. PubMed ID: 16165069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
    Ludwig E; Mészner Z;
    Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal vaccination coverages among low-, intermediate-, and high-risk adults in Catalonia.
    Vila-Corcoles A; Ochoa-Gondar O; Hospital I; de Diego C; Satué E; Bladé J; Ansa X; Guzmán JA; Salsench E; Ramos F
    Hum Vaccin Immunother; 2016 Nov; 12(11):2953-2958. PubMed ID: 27454779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study.
    Vila-Corcoles A; Ochoa-Gondar O; de Diego C; Satue E; Aragón M; Vila-Rovira A; Gomez-Bertomeu F; Magarolas R; Figuerola-Massana E; Raga X; Perez MO; Ballester F
    BMC Infect Dis; 2018 Apr; 18(1):196. PubMed ID: 29699550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coverage of and factors associated with pneumococcal vaccination in chronic obstructive pulmonary disease.
    Carreño-Ibáñez LV; Esteban-Vasallo MD; Domínguez-Berjón MF; Astray-Mochales J; González Del Yerro C; Iniesta-Fornies D; Gascón-Sancho MJ; Jiménez-García R
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):735-41. PubMed ID: 25946369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.
    Tsaban G; Ben-Shimol S
    Vaccine; 2017 May; 35(22):2882-2891. PubMed ID: 28449971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.